All Updates

All Updates

icon
Filter
Funding
EvolutionaryScale raises USD 142 million in seed funding to further develop its models
Foundation Models
Jun 25, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Foundation Models

Foundation Models

Jun 25, 2024

EvolutionaryScale raises USD 142 million in seed funding to further develop its models

Funding

  • EvolutionaryScale, a biotech-focused AI research lab, has raised USD 142 million in a seed funding round led by Nat Friedman, Daniel Gross, and Lux Capital, with participation from Amazon and NVentures.

  • The company plans to use the funds to further expand the capabilities of its protein-generating AI models for scientific research. 

  • EvolutionaryScale develops AI models for applications in the field of biotechnology. The company's core offering, ESM3, is a GenAI model trained on a dataset of 2.78 billion proteins, which can reason over the sequence, structure, and function of proteins, enabling it to generate novel proteins for use in drug discovery and materials science.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.